Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2025-03-05 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
对外投资设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the establishment of a wholly-owned subsidiary. It details the investment overview, legal compliance, approval procedures, and the strategic purpose of the investment. The document explicitly states it is a public announcement about the external investment and the creation of a subsidiary, with no financial statements or detailed financial performance data included. The length is relatively short (2139 characters), and the content is focused on corporate action rather than financial reporting. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as establishing subsidiaries.
2025-03-05 Chinese
关于产品取得医疗器械注册证与通过美国FDA510(K)审核的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the registration of medical devices and passing the FDA 510(k) review. It details the products obtaining medical device registration certificates and FDA clearance, discusses the impact on the company, and includes risk warnings. The document is relatively short (1892 characters) and serves as a formal announcement of regulatory approvals and product certifications rather than a detailed financial or operational report. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-03-05 Chinese
员工持股平台减持股份计划公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement regarding a planned reduction in shareholding by employee shareholding platforms of the company. It details the shareholders involved, the number and proportion of shares to be reduced, the methods and timing of the reduction, compliance with relevant laws and regulations, and risk disclosures. There is no financial data, earnings information, or report attached or referenced as being published. The document is a formal notification of a shareholding reduction plan, which fits the category of Transaction in Own Shares (POS). The document length is under 5,000 characters and is a standalone announcement, not a report or certification.
2025-03-04 Chinese
2024年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a '2024 Annual Performance Express Report' and contains preliminary financial data for the full year 2024, including revenue, net profit, earnings per share, and asset information. It explicitly states that the data is preliminary and unaudited, with final audited figures to be disclosed in the 2024 Annual Report. The document is relatively short (2013 characters) and serves as a quick earnings update rather than a full comprehensive annual report. It includes financial highlights and explanations of performance changes but lacks the full detailed financial statements and notes typical of an Annual Report (10-K). This type of document aligns with an Earnings Release (ER), which provides initial key financial results and performance commentary for a fiscal year before the full annual report is published. FY 2024
2025-02-26 Chinese
北京大成（成都）律师事务所关于四川千里倍益康医疗科技股份有限公司2025年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and procedural compliance of a company's 2025 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholders' meeting process and voting outcomes. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and confirms the legitimacy of the meeting and its resolutions.
2025-01-22 Chinese
2025年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the company's first extraordinary general meeting (临时股东大会决议公告) in 2025. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the meeting's compliance with laws and company regulations. The content focuses on the outcomes of shareholder votes on various proposals, including credit limits, related party transactions, and use of idle funds. There is no detailed financial data or comprehensive report content, but rather the official announcement of voting results from a shareholders' meeting. The document length is 3520 characters, which is relatively short and consistent with a voting results announcement. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-01-22 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.